STAP

April 2016's selection of notable quotes

Social network users rank papers; STAP researcher loses PhD; “tinkering with the fundamentals of life”

Several reports offer an inside look into the stem-cell research controversy.

Ryoji Noyori is stepping down from his post as the leader of the premier Japanese research institute before his tenure expires.

Embryonic stem cells likely mucked up the cultures used in the debunked “stimulus-triggered acquisition of pluripotency” studies.

The stem cell that never was; post-publication peer review website faces legal trouble; biosecurity breaches at federal labs

RIKEN’s Haruko Obokata fails to replicate stimulus-triggered acquisition of pluripotency.

Two coauthors on the now-retracted stimulus-triggered acquisition of pluripotency studies present yet another revision to the published method.

Early versions of two now-retracted stimulus-triggered acquisition of pluripotency studies had been rejected before.  

The Japanese institution will downsize, rename, and relaunch the research center at the heart of the stimulus-triggered acquisition of pluripotency controversy.

Yoshiki Sasai, a prominent organogenesis researcher who was a coauthor on two retracted stem cell studies, has died of apparent suicide at 52, officials say.

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

An institution-wide investigation into labs at the Japanese research institute results in three corrections to papers published in Molecular and Cellular Biology between 2005 and 2010.

Independent analysis uncovers suspected mouse cell mix-up, while stimulus-triggered acquisition of pluripotency lead author Haruko Obokata agrees to retract the work in full.

One of the RIKEN scientists investigating allegations of misconduct tied to stimulus-triggered acquisition of pluripotency work has resigned from the committee because of anonymous questions raised about his own research.

An investigating committee at Japan’s RIKEN research center finds evidence of falsification and fabrication in two recent Nature papers that touted a new way to induce pluripotency.

A stem-cell researcher claims to have reproduced stimulus-triggered acquisition of pluripotency by following a revised protocol posted online last week.

Stem cells supposedly derived by the new method of stimulus-induced acquisition of pluripotency may have come from mouse strains other than those claimed.

Researcher claims his failed attempt to reproduce stimulus-triggered acquisition of pluripotency was rejected for publication.

Nearly two months after researchers published papers showing that they could induce pluripotency with an external stressor, the work’s validity is still being challenged.